These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 24742809)

  • 1. Various MRS application tools for Alzheimer disease and mild cognitive impairment.
    Gao F; Barker PB
    AJNR Am J Neuroradiol; 2014 Jun; 35(6 Suppl):S4-11. PubMed ID: 24742809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Weiss U; Bacher R; Vonbank H; Kemmler G; Lingg A; Marksteiner J
    J Clin Psychiatry; 2003 Mar; 64(3):235-42. PubMed ID: 12716263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal brain aging and Alzheimer's disease are associated with lower cerebral pH: an in vivo histidine
    Lyros E; Ragoschke-Schumm A; Kostopoulos P; Sehr A; Backens M; Kalampokini S; Decker Y; Lesmeister M; Liu Y; Reith W; Fassbender K
    Neurobiol Aging; 2020 Mar; 87():60-69. PubMed ID: 31902521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI).
    Walecki J; Barcikowska M; Ćwikła JB; Gabryelewicz T
    Med Sci Monit; 2011 Dec; 17(12):MT105-11. PubMed ID: 22129910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
    Almuqbel M; Melzer TR; Myall DJ; MacAskill MR; Pitcher TL; Livingston L; Wood KL; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
    Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26627939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment.
    Fayed N; Dávila J; Oliveros A; Medrano J; Castillo J
    Neurol Res; 2010 Mar; 32(2):157-65. PubMed ID: 20158954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment.
    Foy CM; Daly EM; Glover A; O'Gorman R; Simmons A; Murphy DG; Lovestone S
    Brain Topogr; 2011 Oct; 24(3-4):316-22. PubMed ID: 21298332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton MRS in mild cognitive impairment.
    Kantarci K
    J Magn Reson Imaging; 2013 Apr; 37(4):770-7. PubMed ID: 23526756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
    Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
    Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain
    Mitolo M; Stanzani-Maserati M; Capellari S; Testa C; Rucci P; Poda R; Oppi F; Gallassi R; Sambati L; Rizzo G; Parchi P; Evangelisti S; Talozzi L; Tonon C; Lodi R; Liguori R
    Neuroimage Clin; 2019; 23():101843. PubMed ID: 31071594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T.
    Kantarci K; Reynolds G; Petersen RC; Boeve BF; Knopman DS; Edland SD; Smith GE; Ivnik RJ; Tangalos EG; Jack CR
    AJNR Am J Neuroradiol; 2003 May; 24(5):843-9. PubMed ID: 12748083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dementias: diagnostic contribution of imaging and proton magnetic resonance spectroscopy].
    Arana E; Martínez-Granados B; Marti-Bonmati L; Martínez-Bisbal MC; Gil A; Blasco C; Celda B
    Neurologia; 2007 Jun; 22(5):267-74. PubMed ID: 17508300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain metabolism assessed via proton magnetic resonance spectroscopy in patients with amnestic or vascular mild cognitive impairment.
    Zhu X; Cao L; Hu X; Dong Y; Wang H; Liu F; Sun Z
    Clin Neurol Neurosurg; 2015 Mar; 130():80-5. PubMed ID: 25590663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy.
    Modrego PJ; Fayed N; Pina MA
    Am J Psychiatry; 2005 Apr; 162(4):667-75. PubMed ID: 15800137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctive Neurochemistry in Alzheimer's Disease via 7 T In Vivo Magnetic Resonance Spectroscopy.
    Marjańska M; McCarten JR; Hodges JS; Hemmy LS; Terpstra M
    J Alzheimers Dis; 2019; 68(2):559-569. PubMed ID: 30775983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements.
    Kantarci K; Knopman DS; Dickson DW; Parisi JE; Whitwell JL; Weigand SD; Josephs KA; Boeve BF; Petersen RC; Jack CR
    Radiology; 2008 Jul; 248(1):210-20. PubMed ID: 18566174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance spectroscopy in common dementias.
    Kantarci K
    Neuroimaging Clin N Am; 2013 Aug; 23(3):393-406. PubMed ID: 23928196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
    Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cognitive impairment: classification by proton magnetic resonance spectroscopy and the contributions of conventional magnetic resonance imaging].
    Martínez-Bisbal MC; Arana E; Martí-Bonmatí L; Martínez-Granados B; Celda B
    Radiologia; 2006; 48(5):301-7. PubMed ID: 17168239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of 1H MR spectroscopy findings in Alzheimer's disease.
    Soher BJ; Doraiswamy PM; Charles HC
    Neuroimaging Clin N Am; 2005 Nov; 15(4):847-52, xi. PubMed ID: 16443495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.